| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,616 |
9,037 |
$856K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,799 |
5,317 |
$252K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,746 |
3,518 |
$229K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,896 |
1,766 |
$70K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,961 |
4,752 |
$67K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
707 |
674 |
$65K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
740 |
663 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,208 |
2,048 |
$57K |
| 96160 |
|
7,444 |
6,758 |
$54K |
| 97802 |
|
8,825 |
8,270 |
$53K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,282 |
4,036 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,502 |
4,340 |
$39K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
341 |
308 |
$30K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
822 |
797 |
$28K |
| 99215 |
Prolong outpt/office vis |
140 |
137 |
$19K |
| 94760 |
|
1,537 |
1,399 |
$11K |
| 81002 |
|
3,513 |
3,380 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
98 |
94 |
$10K |
| 96127 |
|
1,918 |
1,776 |
$9K |
| 99383 |
|
13 |
13 |
$1K |
| 99381 |
|
15 |
14 |
$1K |
| 96161 |
|
223 |
207 |
$780.61 |
| 82465 |
|
171 |
166 |
$758.05 |
| 99173 |
|
601 |
564 |
$583.13 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
571 |
540 |
$501.00 |
| 85018 |
|
155 |
147 |
$423.92 |
| 92551 |
|
119 |
107 |
$387.10 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
15 |
$238.51 |
| 99188 |
|
13 |
13 |
$238.35 |
| 99072 |
|
3,663 |
3,270 |
$161.53 |
| 87420 |
|
17 |
16 |
$158.30 |
| 36416 |
|
4,283 |
4,103 |
$79.24 |
| 2015F |
|
276 |
274 |
$60.00 |
| 3008F |
|
17,276 |
15,930 |
$55.08 |
| 90670 |
|
190 |
186 |
$23.99 |
| 90647 |
|
71 |
69 |
$10.67 |
| 90461 |
|
486 |
472 |
$3.37 |
| 90686 |
|
1,037 |
1,003 |
$0.22 |
| 90671 |
|
14 |
13 |
$0.06 |
| 90685 |
|
57 |
29 |
$0.00 |
| 5250F |
|
18 |
14 |
$0.00 |
| 90656 |
|
69 |
69 |
$0.00 |
| 90680 |
|
62 |
59 |
$0.00 |
| 99070 |
|
141 |
138 |
$0.00 |
| 99174 |
|
28 |
27 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
15 |
14 |
$0.00 |
| 90723 |
|
30 |
28 |
$0.00 |
| 90688 |
|
71 |
44 |
$0.00 |
| 90620 |
|
12 |
12 |
$0.00 |